Unlock Pichia High level methanol-free phytase production in Pichia pastoris

Similar documents
Pharma&Biotech. XS Microbial Expression Technologies Optimize Productivity, Speed and Process Robustness

Protein Sources (Heterologous expression of proteins)

APPROACHES TO IMPROVING THE PERFORMANCE OF MAMMALIAN CELL CULTURES FOR PROTEIN PRODUCTION

REPORT DOCUMENTATION PAGE

Assessing the fast development of production platforms for renewable chemicals

CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. Section A: DNA Cloning

Lecture Four. Molecular Approaches I: Nucleic Acids

Genetics Lecture 21 Recombinant DNA

Advanced Microbial Protein Expression

AP Biology Gene Expression/Biotechnology REVIEW

2.4 TYPES OF MICROBIAL CULTURE

Module F06FB08. To gain knowledge about enzyme technology and production of enzymes and

SUMOstar Gene Fusion Technology

Future Perspectives of Antibody Manufacturing

7 Gene Isolation and Analysis of Multiple

GUIDELINE FOR THE CONDUCT OF FOOD SAFETY ASSESSMENT OF FOODS PRODUCED USING RECOMBINANT-DNA MICROORGANISMS

Molecular Cell Biology - Problem Drill 11: Recombinant DNA

UNIT II STREPTOMYCIN R.KAVITHA,M.PHARM LECTURER, DEPARTMENT OF PHARMACUTICS SRM COLEGE OF PHARMACY SRMUNIVERITY

ProteoGenix. Life Sciences Services and Products. From gene to biotherapeutics Target Validation to Lead optimisation

CAC/GL Page 1 of 17 GUIDELINE FOR THE CONDUCT OF FOOD SAFETY ASSESSMENT OF FOODS PRODUCED USING RECOMBINANT-DNA MICROORGANISMS CAC/GL

8/21/2014. From Gene to Protein

Biology 201 (Genetics) Exam #3 120 points 20 November Read the question carefully before answering. Think before you write.

CHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? CHAPTER 2A STUDENT GUIDE 2013 Amgen Foundation. All rights reserved.

2 Gene Technologies in Our Lives

Synthetic Biology. Sustainable Energy. Therapeutics Industrial Enzymes. Agriculture. Accelerating Discoveries, Expanding Possibilities. Design.

CHAPTER 17 FROM GENE TO PROTEIN. Section C: The Synthesis of Protein

PRODUCT INFORMATION. Composition of SOC medium supplied :

PREPUBLICATION CODEX PRINCIPLES AND GUIDELINES ON FOODS DERIVED FROM BIOTECHNOLOGY CONTENTS

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

Genetics and Genomics in Medicine Chapter 3. Questions & Answers

CHAPTER 13 LECTURE SLIDES

HI-Control BL21(DE3) & HI-Control 10G Chemically Competent Cells

Preclinical Development Drugs. Darrin Cowley PhD Executive Director Amgen BioBoot Camp 2015

P HENIX. PHENIX PCR Enzyme Guide Tools For Life Science Discovery RESEARCH PRODUCTS

Genetic Engineering for Biofuels Production

White Paper Authentic Recombinant Activin A and BMP- 4 Production Using HumanZyme s Proprietary Human Cell Line Expression Technology

Evolving of Biological Product Expression Systems with Host Cell Engineering

Yeast Two Hybrid Assay: A Fishing Tale

Take the Rational Approach of the BalanCD CHO Media Platform

Microbial Biotechnology agustin krisna wardani

CHAPTER 21 LECTURE SLIDES

Implementation of a Micro Bioreactor System for Platform Cell Culture Process Development at Cobra Biologics

Cat # Box1 Box2. DH5a Competent E. coli cells CCK-20 (20 rxns) 40 µl 40 µl 50 µl x 20 tubes. Choo-Choo Cloning TM Enzyme Mix

1. What is the structure and function of DNA? Describe in words or a drawing the structure of a DNA molecule. Be as detailed as possible.

CRISPR/Cas9 Genome Editing: Transfection Methods

Computational Biology I LSM5191

Sample Question Paper Session Class XII Biotechnology (045) Marking Scheme

Protein Expression PURIFICATION & ANALYSIS. be INSPIRED drive DISCOVERY stay GENUINE

Newsletter Issue 7 One-STrEP Analysis of Protein:Protein-Interactions

Gene Expression Analysis Superior Solutions for any Project

Cultivation of sensitive cell lines - Improving bioreactor performance by dynamic membrane aeration

Optimizing Synthetic DNA for Metabolic Engineering Applications. Howard Salis Penn State University

CHOgro Expression System

Prokaryotic Transcription

Heterologous protein expression systems

FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME INTEGRATED PRODUCTION PLATFORMS GMP-COMPLIANT PRODUCTION OF BIOPHARMACEUTICALS

REGULATION OF GENE EXPRESSION

GeneMATRIX Gram Plus & Yeast Genomic DNA Purification Kit

Chapter 10 Analytical Biotechnology and the Human Genome

Optimization Strategies of Expression Cell Line Construction to Reduce the Biological Drug Development Risk. Feng Gao, MD, PhD. AutekBio CO.

Contents... vii. List of Figures... xii. List of Tables... xiv. Abbreviatons... xv. Summary... xvii. 1. Introduction In vitro evolution...

TightRegulation, Modulation, and High-Level Expression byvectors ContainingtheArabinose Promoter

E. coli and mammalian cells : most widely used

Biological immune systems

GENE REGULATION IN PROKARYOTES

ENDEXT TM Technology. Wheat Germ Premium Expression Kit. Ver 1.7. CellFree Sciences Co., Ltd.

How Do You Clone a Gene?

Fig Ch 17: From Gene to Protein

Manufacturing Integrated Biologics Manufacturing

Improved method for assembly of linear yeast expression cassettes using NEBuilder HiFi DNA Assembly Master Mix

CASY Model TT E L E C T R I C A L C U R R E N T EXCLUSION ECE BASED CELL ANALYSIS

strain devoid of the aox1 gene [1]. Thus, the identification of AOX1 in the intracellular

Chapter 15 Gene Technologies and Human Applications

Subject Index. chromatography step, 125-

Molecular Cell Biology - Problem Drill 01: Introduction to Molecular Cell Biology

Lecture 3 (FW) January 28, 2009 Cloning of DNA; PCR amplification Reading assignment: Cloning, ; ; 330 PCR, ; 329.

Chapter 13 - Concept Mapping

2054, Chap. 14, page 1

Genome Biology and Biotechnology

2054, Chap. 13, page 1

Chapter 9. Biotechnology and DNA Technology

BIOTECHNOLOGY OLD BIOTECHNOLOGY (TRADITIONAL BIOTECHNOLOGY) MODERN BIOTECHNOLOGY RECOMBINANT DNA TECHNOLOGY.

Bioremediation What is it and how does it work?

THE BENEFITS AND USES OF MICROBES

CREATING TOMORROW S SOLUTIONS BIOPHARMACEUTICALS I CONTRACT MANUFACTURING WACKER BIOTECH: THE MICROBIAL CMO

Total Test Questions: 66 Levels: Grades Units of Credit: 1.0 STANDARD 2. Demonstrate appropriate use of personal protective devices.

Biotechnology. Chapter 20. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for

Total Test Questions: 71 Levels: Grades Units of Credit: 1.0 STANDARD 1 STUDENTS WILL INVESTIGATE THE PAST, PRESENT, AND FUTURE APPLICATIONS OF

Recombinant Antibody Production in Therapeutic Antibody Projects. Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016

Module I: Introduction

Annex to the Accreditation Certificate D PL according to DIN EN ISO/IEC 17025:2005

Chapter 4: How Cells Work

Hollow Fiber Bioreactors: Single-Use. Perfusion. Scalable. Continuous Manufacturing.

TransIT-PRO Transfection Reagent Protocol for MIR 5740 and 5750

ARBRE-P4EU Consensus Protein Quality Guidelines for Biophysical and Biochemical Studies Minimal information to provide

i) Wild animals: Those animals that do not live under human supervision or control and do not have their phenotype selected by humans.

Droplet microfluidic for high-throughput screening of microorganisms based on enzymatic activities From bacteria to fungi communities

GENE EXPRESSION AND EXPERIMENTAL READOUTS ON THE TURNER BIOSYSTEMS FAMILY OF INSTRUMENTS

Enhancers mutations that make the original mutant phenotype more extreme. Suppressors mutations that make the original mutant phenotype less extreme

Transcription:

WHITE PAPER Unlock Pichia High level methanol-free phytase production in Pichia pastoris Thomas Purkarthofer, Evelyn Trummer-Gödl, Iskandar Dib, Roland Weis VTU Technology GmbH, Parkring 18, 8074 Raaba-Grambach, Austria office.technology@vtu.com www.vtu-technology.com

Introduction Pichia pastoris is recognized as a highly competitive expression system for fast and economic production of recombinant proteins. It combines advantageous properties of prokaryotes and mammalian cells. On one hand, Pichia cultures grow fast and can reach high cell densities on inexpensive and chemically defined media, on the other hand, the organism has a subcellular protein processing machinery, which is required for post-translational modification and active secretion of proteins. Simplicity of genetic manipulation and high productivity paired with the capability to secrete recombinant proteins efficiently further underline the capabilities of Pichia pastoris for both R&D and commercial production. Levels of endogenous proteins in the culture supernatant are low, furnishing a raw product with high purity. Thus, Pichia not only enables cultivation processes with high volumetric productivity but also simplifies downstream processes rendering manufacturing of recombinant proteins even more economically viable. Today, Pichia is used for the manufacture of numerous commercial products, including biologics, with a constantly growing list of clinical candidates, food & feed enzymes, research proteins and technical enzymes. A significant milestone for Pichia pastoris as a production host in food technology was when the U.S. FDA awarded the GRAS (generally recognized as safe) status for recombinant phospholipase C from Pichia applied for degumming of vegetable oils. The AOX1 promoter (PAOX1) - in its native function controlling the expression of an enzyme from the methanol metabolism called alcohol oxidase 1 - is the promoter most often applied for recombinant protein production with Pichia pastoris. PAOX1 is strongly repressed in the presence of common carbon sources such as glucose and glycerol. Upon depletion of these carbon sources, the promoter is derepressed and elicits its full activity when induced with methanol. An important practical aspect of this tight regulation is during the initial phase of bioreactor cultivation in the presence of repressing carbon sources in order to avoid cellular metabolism being hampered by heterologous protein expression. Nevertheless, in some cases safety precautions are an obstacle for implementation of methanol-induced Pichia cultivation processes at large scale. As a consequence, alternative promoters, which do not require induction with methanol, while still exhibiting tight regulation patterns and furnishing high expression levels, are desired. Based on Pichia s inherent potential, VTU Technology established an exclusive and yield-enhancing protein production technology toolbox the core of which is the company s cutting edge AOX1 promoter library. The library is composed of alterations of active sequence elements, such as transcription factor binding sites, resulting in variants with different strength and regulatory properties. After careful selection of the perfect match of promoter variant with a particular gene of interest these differences allow for optimization of protein production by fine-tuning of expression levels. At VTU Technology promoter variants are applied simultaneously in pools of expression constructs with the gene of interest and genes encoding for different auxiliary proteins, thereby generating a broad diversity of genetic arrangements and expression profiles. In this setting, protein production in Pichia pastoris is boosted significantly. Following specialized protocols, thousands of clones can be screened in minimum time and most promising clones will be reliably identified already at microscale. Results of microplate screening are transferable into much larger bioreactors making laborious intermediate steps for clone comparison obsolete. White Paper, March 2017 VTU Technology GmbH 2

Without Methanol A subset of VTU Technology s AOX1 promoter variants has been found to elicit high productivities already during the derepression phase i.e. at low concentrations of glycerol or glucose. Thus, methanol feed for induction can be omitted and strong expression is facilitated even with just glycerol or glucose as the sole carbon source. Apart from abolishing toxic and explosive methanol as a substrate and retaining high expression levels, major additional advantages of this new technology are reduced oxygen consumption and therefore significantly reduced heat production and cooling effort in bioreactor cultivation as well as a significant potential to reduce process time and cost of goods. Case Study: Production of a Recombinant Phytase Using the VTU Pichia Expression System Phytases catalyze the stepwise removal of phosphate from phytic acid and its salt phytate, a storage compound of phosphorus in plants. Recombinant (native and engineered) phytases from different sources such as fungi and bacteria are applied as additives in animal feed for monogastric animals such as swine, poultry, and fish. The current annual phytase market is estimated to be about 350 million USD. Harnessing VTU Technology s Pichia pastoris protein expression technologies and screening know-how in a case study, the production of an engineered variant of Butiauxella sp. phytase yielded 22 g/l of enzyme in a methanol-induced process and 20 g/l under methanol-free conditions, constituting the highest amounts of yeast-produced recombinant phytase reported so far. Procedures All media components used during expression strain generation as well as bioreactor cultivations are certified to be free of any animal derived components and contaminations resulting thereof. For regulatory purposes, no antibiotic selection markers were applied and full documentation is available for strains and all genetic elements used in a ready to file status. Initially, two different PAOX1 variants for MeOH-induced and two different PAOX1 variants for MeOH-free production were tested in a screening of 400 clones each in order to assess the expressibility of the target phytase in Pichia (small screening). After simultaneous transformations (pool of two constructs each) and selection, clones were cultivated in 96-deep well plates according to VTU s specialized procedures. Supernatants were screened for phytase concentration and activity by microfluidic capillary electrophoresis (mce) measurements and by DiFMUP (6,8-difluoro-4-methylumbelliferyl phosphate) assay. Subsequently, in a second comprehensive development phase (extended screening), nine different PAOX1 variants (both MeOH-induced and MeOH-free) were applied in a screening of a total of 6000 clones each. After each microscale cultivation and screening step, the most productive clones were cultivated in 0.75 L bioreactors following VTU s established generic protocols without any further optimization of cultivation conditions. White Paper, March 2017 VTU Technology GmbH 3

Results and Discussion As expected, the initial screenings after transformations with constructs carrying only two different AOX1 promoter variants for either MeOH-induced or MeOH-free production returned somewhat varying expression and activity levels. The most promising clones were assessed by cultivation in 0.75 L bioreactors. The final phytase concentrations in the cultures supernatants reached 6.2 g/l with MeOH induction and 4.2 g/l in the MeOH-free process. The relatively high productivities obtained in this initial stage of strain development indicated that Pichia pastoris is a well suited host for the production of recombinant Butiauxella sp. phytase. The application of a higher number of promoter variants from VTU s technology toolbox as a pool typically leads to a significant productivity boost leveraging random genetic diversity and concomitant fine-tuning and optimization of gene dosage. In this study with nine AOX1 variants in the large screening, a landscape of different expression levels was observed and productivity increased by a factor of around four. Phytase concentrations reached 22 g/l (MeOH-induction) and 20 g/l (MeOH-free) in the supernatants at the end of bioreactor cultivations of most promising clones identified in microscale (Figure 1). Figure 1: Methanol-induced and methanol-free production of Butiauxella sp. phytase in VTU Pichia pastoris. Titers reached with final strains were 22 g/l for methanol-induced conditions and 20 g/l for the methanol free process. The improvement through increasing genetic diversity (increasing VTU s promoter variants and clone numbers) was 3.5 and 4.6-fold, respectively. These results clearly underline the usefulness of VTU s AOX1 promoter library and the company s entire expression toolbox as well as strain development and cultivation protocols to unlock Pichia as a powerful host for recombinant protein production. Using our approach, we could demonstrate that increasing the screening size by broadening the pool of AOX1 promoter variants in expression constructs used for transformation leads to a significant improvement of product yields. Despite the advantages of tightly regulated PAOX1 driven expression, the necessity for induction with methanol is sometimes considered problematic because of safety concerns, especially for the large-scale production. This case study reveals that the appealing features of PAOX1 driven expression such as tight regulation of the production process while facilitating high-level protein production are equally effective with VTU Technology s MeOH-free AOX1 promoter variants. White Paper, March 2017 VTU Technology GmbH 4

To conclude, VTU Technology s AOX1 promoter variants enable the economic production of recombinant target proteins in commercial quantities using a robust, reproducible and scalable processing method. This is achieved through the versatility of this promoter library in fine-tuning of protein expression. A special subset of these AOX1 variants is used in production processes without the need for methanol induction. Thereby, double-digit g/l levels of recombinant proteins are realized in Pichia production processes with glycerol as the sole carbon source. White Paper, March 2017 VTU Technology GmbH 5